Covered recipient · General Payments record
DESIREE N STATLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,599.89
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $688.39 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $132.97 | 3 |
| Janssen Scientific Affairs, LLC | $121.41 | 1 |
| DEXCOM, INC. | $107.05 | 3 |
| SCPHARMACEUTICALS INC. | $106.00 | 1 |
| ABBVIE INC. | $66.16 | 4 |
| Lilly USA, LLC | $65.58 | 1 |
| Novo Nordisk AS | $56.08 | 3 |
| PFIZER INC. | $19.56 | 1 |
| GlaxoSmithKline, LLC. | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247008 | CMS |
| ABBVIE INC. | $21.54 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247010 | CMS |
| ABBVIE INC. | $15.74 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247012 | CMS |
| ABBVIE INC. | $13.65 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108247014 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.10 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104633631 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.39 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383847 | CMS |
| AstraZeneca Pharmaceuticals LP | $111.48 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105667288 | CMS |
| Dexcom, Inc. | $45.24 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153357859 | CMS |
| Dexcom, Inc. | $24.32 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153357861 | CMS |
| Dexcom, Inc. | $37.49 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153357863 | CMS |
| GlaxoSmithKline, LLC. | $13.58 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116528256 | CMS |
| Janssen Scientific Affairs, LLC | $121.41 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078848105 | CMS |
| Lilly USA, LLC | $65.58 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135570513 | CMS |
| Novo Nordisk Inc | $17.86 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100471813 | CMS |
| Novo Nordisk Inc | $19.28 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100260207 | CMS |
| Novo Nordisk Inc | $18.94 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100346334 | CMS |
| PFIZER INC. | $19.56 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131175971 | CMS |
| SCPHARMACEUTICALS INC. | $106.00 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132248248 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.